Shi Zhongyong, Cao Xinyi, Hu Jingxiao, Jiang Lijuan, Mei Xinchun, Zheng Hailin, Chen Yupeng, Wang Meijuan, Cao Jing, Li Wei, Li Ting, Li Chunbo, Shen Yuan
Department of Psychiatry, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, PR China; Anesthesia and Brain Research Institute, Tongji University School of Medicine, Shanghai 200072, PR China.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, PR China.
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109824. doi: 10.1016/j.pnpbp.2019.109824. Epub 2019 Nov 23.
Abnormal retina structures, such as thinner retinal nerve fiber layer (RNFL), have been frequently reported in patients with Alzheimer's disease (AD). However, the association between RNFL and brain structures in cognitively normal adults remains unknown. We therefore set out to conduct a cross-sectional investigation to determine whether RNFL thickness is associated with brain structure volumes in nondemented older adults.
We measured RNFL thickness by optical coherence tomography and brain structure volumes by 3 T magnetic resonance imaging. Cognitive function was assessed using the Chinese version of Repeatable Battery for the Assessment of Neurological Status. Pearson correlation was initially employed to screen for the potential associations among RNFL thickness, brain structure volumes and cognitive function. And then, multivariable linear regression models were conducted to further examine such associations adjusting for possible confounding factors, including age, sex, years of education and the estimated total intracranial volume (eTIV).
113 participants (≥ 65 years old) were screened and 80 of them (mean age: 68 ± 5.3 years; 48% male) were included in the final analysis. RNFL thickness in temporal quadrant was associated with medial temporal lobes volumes [unadjusted: r = 0.155, P = 0.175; adjusted: β = 0.205 (0.014, 0.383), P = 0.035], and especially associated with the hippocampus volume [unadjusted: r = 0.213, P = 0.062; adjusted: β = 0.251 (0.060, 0.435), P = 0.011] after adjusted for age, sex, years of education and eTIV. Moreover, it showed that RNFL thickness in inferior quadrant [unadjusted: r = 0.221, P = 0.052; adjusted: β = 0.226 (0.010. 0.446), P = 0.041] was significantly associated with occipital lobes volumes after the adjustment of age, sex, years of education and eTIV, and selectively associated with the substructure of lingual gyrus volume [unadjusted: r = 0.223, P = 0.050; adjusted: β = 0.278 (0.058, 0.487), P = 0.014]. In addition, average RNFL thickness was associated with the cognitive domain of visuospatial/constructional [unadjusted: r = 0.114, P = 0.322; adjusted: β = 0.216 (0.006, 0.426), P = 0.044] after the adjustment in these nondemented older adults.
Quadrant-specific associations exist between RNFL thickness and brain regions vulnerable to aging or neurodegeneration in older adults with normal cognition. These findings would promote further investigations into using RNFL as a noninvasive and less expensive biomarker of neurocognitive aging and AD-related neurodegeneration.
阿尔茨海默病(AD)患者中常出现视网膜结构异常,如视网膜神经纤维层(RNFL)变薄。然而,认知正常成年人的RNFL与脑结构之间的关联尚不清楚。因此,我们开展了一项横断面研究,以确定非痴呆老年人的RNFL厚度是否与脑结构体积相关。
我们通过光学相干断层扫描测量RNFL厚度,通过3T磁共振成像测量脑结构体积。使用中文版可重复性神经心理状态评估量表评估认知功能。最初采用Pearson相关性分析来筛选RNFL厚度、脑结构体积和认知功能之间的潜在关联。然后,进行多变量线性回归模型,以进一步检验在调整可能的混杂因素(包括年龄、性别、受教育年限和估计的总颅内体积(eTIV))后的此类关联。
筛选出113名参与者(≥65岁),其中80名(平均年龄:68±5.3岁;48%为男性)纳入最终分析。颞侧象限的RNFL厚度与内侧颞叶体积相关[未调整:r = 0.155,P = 0.175;调整后:β = 0.205(0.014,0.383),P = 0.035],在调整年龄、性别、受教育年限和eTIV后,尤其与海马体积相关[未调整:r = 0.213,P = 0.062;调整后:β = 0.251(0.060,0.435),P = 0.011]。此外,在调整年龄、性别、受教育年限和eTIV后,下象限的RNFL厚度[未调整:r = 0.221,P = 0.052;调整后:β = 0.226(0.010,0.446),P = 0.041]与枕叶体积显著相关,并与舌回体积的子结构选择性相关[未调整:r = 0.223,P = 0.050;调整后:β = 0.278(0.058,0.487),P = 0.014]。此外,在这些非痴呆老年人中进行调整后,平均RNFL厚度与视觉空间/构建认知领域相关[未调整:r = 0.114,P = 0.322;调整后:β = 0.216(0.006,0.426),P = 0.044]。
认知正常的老年人中,RNFL厚度与易发生衰老或神经退行性变的脑区之间存在象限特异性关联。这些发现将促进进一步研究将RNFL用作神经认知衰老和AD相关神经退行性变的非侵入性且成本较低的生物标志物。